On November 26, 2025, Johnson & Johnson Director John G. Morikis purchased 1,250 shares of the company for a total investment of $257,687.50, reflecting a price of $206.15 per share. This transaction is notable as it occurred within a six-month period where only eight companies in the Dow Jones Industrial Average saw insider purchases, indicating Morikis’s confidence in the company’s potential.
As of the latest trading session, Johnson & Johnson shares were at $245.50, down approximately 0.7%, with a 52-week range of $141.50 to $251.71. The company also offers an annualized dividend of $5.20 per share, yielding about 2.1%, with the most recent dividend ex-date listed as February 24, 2026.
